Access cutting-edge anemia treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access anemia specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related anemia treatment provided free
Stage A: To evaluate the safety and efficacy of red blood cells (RBCs) prepared with the INTERCEPT Blood System for Red Blood Cells Pathogen Reduction Treatment (PRT) in comparison to conventional RBCs in patients who require RBC transfusion support. Stage B: To provide early access to the INTERCEPT pathogen reduction system for RBC in regions where a substantial proportion of the population has been infected or is at risk of a transfusion-transmissible infection. The objectives and design of
Sponsor: Cerus Corporation
Check if you qualify for this anemia clinical trial in Baltimore, MD
If you're searching for anemia treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.